IP Library Granted Patent US 11,266,750
Granted Patent B2
US 11,266,750 · App. 17/325,176 · Granted Mar 8, 2022

Methods for making ultrasound contrast agents

Inventors: Simon P. Robinson (Stow, MA); Robert W. Siegler (Chelmsford, MA); Nhung Tuyet Nguyen (Westford, MA); David C. Onthank (Groton, MA); Tarakeshwar Vishwanath Anklekar (Billerica, MA); Charles Chester Van Kirk (Beverly, MA)
Assignee: Lantheus Medical Imaging, Inc.
A61K49/223A61B8/481A61K49/226A61K49/227C07F9/09C07F9/106
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,266,750
App. No.
17/325,176
Granted
Mar 8, 2022
Kind
B2
Abstract

Provided herein are improved methods for preparing phospholipid formulations including phospholipid UCA formulations.

Claims (20)

1. A method of ultrasound contrast imaging a subject comprising

selecting an MPEG5000-DPPE having a calcium concentration of less than 115 parts per million (ppm),

combining the MPEG5000-DPPE with DPPA, DPPC and propylene glycol, to form a phospholipid solution having a calcium concentration of less than 0.7 ppm,

combining the phospholipid solution with an aqueous solution to form a phospholipid suspension,

activating the phospholipid suspension with a perfluorocarbon gas to form lipid-encapsulated gas microspheres,

administering the lipid-encapsulated gas microspheres to a subject, and

obtaining an ultrasound image of the subject.

2. The method of claim 1 , wherein DPPA, DPPC and MPEG-5000-DPPE are present in the phospholipid solution in a mole % ratio of 10 to 82 to 8 (10:82:8).

3. The method of claim 1 , wherein DPPA has a calcium concentration of less than 780 ppm, DPPC has a calcium concentration of less than 90 ppm, and propylene glycol has a calcium concentration of less than 0.7 ppm.

4. The method of claim 1 , wherein the perfluorocarbon gas is perfluoropropane gas.

5. A method of ultrasound contrast imaging a subject comprising

selecting an MPEG5000-DPPE having a combined calcium and magnesium concentration of less than 115 parts per million (ppm),

combining the MPEG5000-DPPE with DPPA, DPPC and propylene glycol, to form a phospholipid solution having a combined calcium and magnesium concentration of less than 0.7 ppm,

combining the phospholipid solution with an aqueous solution to form a phospholipid suspension,

activating the phospholipid suspension with a perfluorocarbon gas to form lipid-encapsulated gas microspheres,

administering the lipid-encapsulated gas microspheres to a subject, and

obtaining an ultrasound image of the subject.

6. The method of claim 5 , wherein DPPA, DPPC and MPEG-5000-DPPE are present in the phospholipid solution in a mole % ratio of 10 to 82 to 8 (10:82:8).

7. The method of claim 5 , wherein DPPA has a combined calcium and magnesium concentration of less than 780 ppm, DPPC has a combined calcium and magnesium concentration of less than 90 ppm, and propylene glycol has a combined calcium and magnesium concentration of less than 0.7 ppm.

8. The method of claim 5 , wherein the perfluorocarbon gas is perfluoropropane gas.

Assignments (2)
SECURITY INTEREST Recorded Dec 2, 2022
From: LANTHEUS MEDICAL IMAGING, INC.; MOLECULAR INSIGHT PHARMACEUTICALS, INC.; PSMA DEVELOPMENT COMPANY, LLC; PROGENICS PHARMACEUTICALS, INC.
To: CITIZENS BANK, N.A.
Reel/Frame 062047/0960 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2021
From: ROBINSON, SIMON P.; SIEGLER, ROBERT W.; NGUYEN, NHUNG TUYET; ONTHANK, DAVID C.; VAN KIRK, CHARLES CHESTER; ANKLEKAR, TARAKESHWAR VISHWANATH
To: LANTHEUS MEDICAL IMAGING, INC.
Reel/Frame 057110/0937 →
Cited By (1)
US 12,296,029